Our approach is based on extensive research on Proteasome Activation , focusing on increasing proteasome concentrations—an innovative technique in proteostasis management.
Our proprietary methodology is the cornerstone of our approach, allowing for the elevation of proteasome concentrations to efficiently reduce and clear misfolded and damaged proteins—a unique technique with substantial therapeutic potential.
At the heart of our innovation lies the development of an active ingredient—proteasome activator (PA). This compound holds the promise of patent protection, safeguarding our intellectual property.
Our approach is based on extensive research on Proteasome Activation , focusing on increasing proteasome concentrations—an innovative technique in proteostasis management.
We're committed to a streamlined development process. Our therapy's optimization on human fibroblasts demands minimal financial investment and significantly shorter timelines, ensuring rapid progress.
Improving keratinization, reducing scaling caused by misfolded proteins.
Targeting misfolded proteins to reduce blistering and inflammation
Mitigating sun sensitivity and skin cancer risk by addressing misfolded proteins related to DNA repair.
Preventing amyloid deposits and associated skin manifestations by reducing misfolded proteins.
Alleviating fragile skin and blistering by addressing misfolded proteins.
Alleviating scaling and inflammation by addressing misfolded proteins related to skin barrier function.
Mitigating inflammatory responses by targeting misfolded proteins involved in immune dysregulation.
Modulating mast cell activity and alleviating itching and skin lesions through the removal of misfolded proteins.
Improving skin elasticity, firmness, and quality by addressing misfolded proteins involved in skin aging.